|
Guideline-based surveillance and treatment of hepatocellular carcinoma
|
5R01CA160738-03
|
$244,203
|
$244,203
|
Davila, Jessica
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S1
|
$75,000
|
$750
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S2
|
$43,265
|
$433
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-07
|
$3,092,811
|
$30,928
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT
|
1R01CA183605-01
|
$573,875
|
$573,875
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Bone Deficits and Excess Adiposity after Pediatric Bone Marrow Transplantation
|
1K07CA166177-01A1
|
$165,004
|
$165,004
|
Mostoufi-Moab, Sogol
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Novel Therapeutic Targets For Calcineurin Inhibitor-Induced And mTOR-Mediated Can
|
1R21CA172946-01A1
|
$228,375
|
$228,375
|
Pal, Soumitro
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Pathophysiology of Post-Transplantation Cancer
|
5R01CA131145-05
|
$329,206
|
$329,206
|
Pal, Soumitro
|
CHILDREN'S HOSPITAL CORPORATION
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
5R01CA113969-09
|
$306,016
|
$153,008
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Nonadherence: Undermining health outcomes in pediatric HSCT?
|
5R01CA157460-02
|
$479,328
|
$479,328
|
PAI, AHNA
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
5R01CA157537-03
|
$298,427
|
$298,427
|
PANG, QISHEN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Anthraycline-related cardiotoxicity in long-term survivors of lymphoma
|
1R21CA178344-01
|
$189,963
|
$94,982
|
ARMENIAN, SARO
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccine
|
5R01CA077544-12
|
$84,049
|
$84,049
|
Diamond, Don
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-08
|
$2,150,500
|
$537,625
|
Forman, Stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
2P30CA033572-30
|
$2,042,489
|
$61,275
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-30S1
|
$125,000
|
$3,750
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-30S2
|
$52,354
|
$1,571
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-30S3
|
$10,680
|
$320
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
5U10CA046368-26
|
$340,319
|
$3,403
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Evaluating New Targets of CMV Cellular Immunity
|
5R01CA145207-08
|
$369,551
|
$369,551
|
Zaia, John
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Multi-Method Study of Cancer Patients' Medication Adherence After Allogeneic HSCT
|
5R03CA162980-03
|
$75,200
|
$75,200
|
Stadler, Gertraud
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Host-tumor cell interaction in myeloma: therapeutic applications
|
5P01CA078378-14
|
$1,841,280
|
$460,320
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-21
|
$262,054
|
$39,308
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
Mechanisms of GVHD
|
5P01CA142106-10
|
$1,755,269
|
$1,755,269
|
ANTIN, JOSEPH
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-48S1
|
$114,538
|
$9,163
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-48S3
|
$12,500
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-48S4
|
$50,000
|
$4,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-48
|
$10,435,722
|
$834,858
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Integrative Oncogenomics of Multiple Myeloma
|
5P01CA155258-03
|
$1,875,926
|
$168,833
|
MUNSHI, NIKHIL
|
DANA-FARBER CANCER INST
|
|
Reconstitution of Regulatory T Cells After Stem Cell Transplantation
|
1R01CA183560-01
|
$500,000
|
$500,000
|
RITZ, JEROME
|
DANA-FARBER CANCER INST
|
|
Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation
|
1R01CA183559-01
|
$700,000
|
$700,000
|
Soiffer, Robert
|
DANA-FARBER CANCER INST
|
|
Novel Approaches to Stem Cell Transplantation
|
5P01CA047741-20
|
$1,669,869
|
$1,669,869
|
Chao, Nelson
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-39S1
|
$18,744
|
$1,687
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-39
|
$5,351,774
|
$481,660
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Inhibition of Cytochrome c-induced Caspase Activation
|
5R01CA102707-09
|
$247,272
|
$81,600
|
KORNBLUTH, SALLY
|
DUKE UNIVERSITY
|
|
Home-Based Tablet Computer Pain Coping Skills Following Stem Cell Transplant
|
1R21CA173307-01A1
|
$204,885
|
$204,885
|
Somers, Tamara
|
DUKE UNIVERSITY
|
|
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant
|
5R01CA136934-05
|
$295,150
|
$295,150
|
YANG, YIPING
|
DUKE UNIVERSITY
|
|
Adult Leukemia Research Center
|
5P01CA018029-38
|
$3,971,921
|
$2,065,399
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CAN RES CTR
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-15
|
$596,700
|
$298,350
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CAN RES CTR
|
|
Pediatric Oncology Research Training Program
|
5T32CA009351-35
|
$239,826
|
$95,930
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CAN RES CTR
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-03
|
$170,100
|
$170,100
|
Bleakley, Marie
|
FRED HUTCHINSON CAN RES CTR
|
|
Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W
|
1K08CA169485-01A1
|
$171,372
|
$171,372
|
Chapuis, Aude
|
FRED HUTCHINSON CAN RES CTR
|
|
Analysis of Morbidity and Mortality Among Hematopoietic Cell Transplantation Surv
|
1R03CA167451-01A1
|
$88,000
|
$88,000
|
Chow, Eric
|
FRED HUTCHINSON CAN RES CTR
|
|
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
|
5K07CA151775-03
|
$151,059
|
$151,059
|
Chow, Eric
|
FRED HUTCHINSON CAN RES CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S1
|
$109,383
|
$16,407
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S2
|
$18,750
|
$2,813
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S3
|
$125,000
|
$18,750
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S4
|
$50,000
|
$7,500
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
5P30CA015704-39
|
$10,072,717
|
$1,510,908
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Radioimmunotherapy for Multiple Myeloma
|
5K08CA151682-04
|
$169,560
|
$42,390
|
Green, Damian
|
FRED HUTCHINSON CAN RES CTR
|
Total relevant funding to Organ Transplantation Research for this search: $59,220,422
|